中文 | English
Return
Total: 80 , 1/8
Show Home Prev Next End page: GO
Author:(Xi BU)

1.Triple negative breast cancer:a study based on histological and immunohistochemical classification

Jing LIAN ; Li HUANG ; Peng BU ; Hong SU ; Yanfeng XI

Chinese Journal of Clinical and Experimental Pathology 2024;40(3):268-273

2.Mechanism of Tongxie yaofang reducing colon hypermotility in IBS-D rats by regulating gut microbiota-ENS-MM crosstalk

Long PENG ; Jiale MA ; Yixuan YIN ; Xi BU ; Shuangmei ZHAO

China Pharmacy 2024;35(13):1605-1611

3.Efficacy and safety evaluation of recombinant human growth hormone in treatment of pediatric patients with GHD and ISS based on propensity scores

Xi YANG ; Xu ZHANG ; Yanxia MA ; Mei HAN ; Zikun TAO ; Weixiao BU ; Huaxia MU ; Yaqi XU ; Suzhen WANG ; Fuyan SHI

Journal of Jilin University(Medicine Edition) 2024;50(6):1703-1711

4.Biological characteristics of triple negative breast cancer with low expression of HER2

Jing LIAN ; Ruoqi LI ; Lei YAN ; Peng BU ; Huiwen WANG ; Yanfeng XI

Chinese Journal of Pathology 2024;53(9):898-904

5.Application of magnetic resonance imaging with intraoperative color Doppler ultrasound in the treatment of patients with polyacrylamide hydrogel injected for breast augmentation: a retrospective study of 204 cases for 12 years

Xi BU ; Jian-Xun MA ; You-Chen XIA ; Bi LI ; Yue LANG ; Shi-Lu YIN

Annals of Surgical Treatment and Research 2024;106(1):31-37

7.Relationship between ITGA3 expression and immune cell infiltration in colorectal cancer

Xiao LIU ; Yanfeng XI ; Peng BU ; Guohai ZHAO ; Peiyu JIN ; Yuting FENG ; Wei CUI ; Jing XU

Chinese Journal of Clinical Oncology 2023;50(23):1196-1202

10.The Application of Cartilage Tissue Engineering with Cell-Laden Hydrogel in Plastic Surgery: A Systematic Review

Guanhuier WANG ; Xinling ZHANG ; Xi BU ; Yang AN ; Hongsen BI ; Zhenmin ZHAO

Tissue Engineering and Regenerative Medicine 2022;19(1):1-9

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 80 , 1/8 Show Home Prev Next End page: GO